Brain

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
26021
Observation versus conventional-fractionated radiotherapy or radiosurgery after non-radical surgery for benign intracranial meningiomas : a phase III study
26034
Randomized phase II of TARCEVA TM (Erlotinib) versus Temozolomide or BCNU in patients with recurrent glioblastoma multiforme.
16011
Open Label Phase II Study on STI571 Administered As a daily Oral Treatment In Gliomas
16994G
 Open Label Phase II study on Glufosfamide administered as a 60 minute infusion every 3 weeks in recurrent Glioblastoma Multiforme
26981
"Concomitant and adjuvant Temozolomide and Radiotherapy for newly diagnosed glioblastoma multiforme. A randomized phase III study"
16996G
 Open label Phase II on RFS 2000 (9-Nitro-camptothecin,9-NC) administered as a "5 days on-2 days off" oral treatment in glioblastoma multiforme - EORTC Study 16996G
16991G
 Open Label phase II study on XR5000 administered as a 5 day infusion in patients with glioblastoma multiforme: EORTC study 16991G
22972
 Focal fractionated conformal stereotactic boost following conventional radiotherapy of high grade gliomas: A randomized phase III study. (Joint study of the MRC and EORTC Radiotherapy Cooperative Group and the Brain Tumor Cooperative Group) EORTC 22972/26991-MRC BR10
26971
First line chemotherapy with Temozolomide in recurrent oligodendroglial tumors, a phase II trial.
26972
Second line chemotherapy with Temozolomide in recurrent oligodendroglial tumors after PCV-chemotherapy,a phase II trial.
11961
Postoperative Treatment of Glioblastoma with BNCT at the Petten Irradiation Facility
26952
Treatment of primary CNS lymphoma in immunocompetent patients aged over 60 years with chemotherapy alone : A phase II trial
26951
Phase III study of adjuvant Procarbazine, CCNU and Vincristine chemotherapy in patients with highly anaplastic oligodendroglioma (randomized)
26882
Phase III trial on the effect of Dibromodulcitol plus BCNU on free interval and survival of patients with supratentorial malignant brain gliomas
26921
Effect of procarbazine, CCNU and vincristine combination on free interval and survival of adults with supratentorial anaplastic astrocytomas
22933
Accelerated radiotherapy with Carbogen and Nicotinamide (ARCON) for glioblastoma. A phase I-II study
26883
PHASE II TRIAL ON THE EFFECT OF VINCRISTINE + NIMODIPINE COMBINED CHEMOTHERAPY IN RECURRENT MALIGNANT BRAIN GLIOMAS FOR PATIENTS ALREADY TREATED WITH CHEMOTHERAPY .
26881
Phase II/III trial on the effect of Vincristine + Nimodipine association combined with BCNU versus BCNU alone in recurrent malignant brain gliomas
04891
Essais cliniques phase II d'une nouvelle nitrosourée: la Cystémustine dans les poumons, les adénocarcinomes colo-rectaux, les gliomes, les mélanomes, les reins, les sarcomes des parties molles et les tumeurs de la tête et du cou.
08873
E.O.R.T.C. BRONCHIAL COOPERATIVE GROUP TENIPOSIDE FOR BRAIN METASTASES OF SMALL CELL LUNG CANCER.
22845
Phase III trial of radiation therapy vs no radiation therapy for cerebral gliomas (low grade astrocytoma and oligodendroglioma) of the adult (Joint study of the EORTC Radiotherapy Cooperative Group, the EORTC Brain Tumor Cooperative Group and the Medical Research Council (UK))
26851
Phase III trial comparing the effect of cisplatinum given during radiation therapy to radiation therapy alone in patients with supratentorial malignant brain gliomas.
22844
Phase III trial on low dose vs high dose radiation therapy for cerebral gliomas ( low grade astrocytoma and olidendroglioma) of the adult (Jointly with the EORTC Radiotherapy Cooperative Group)
08841
Phase II Chemotherapy with High-Dose VP-16213 for Brain Metastases in Patients with Small Cell Lung Cancer
26061
Phase II study of Epothilone ZK 219477 in patients with recurrent glioblastoma
26041
Phase I/II study on concomitant and adjuvant Temozolomide and Radiotherapy with or without PTK787/ZK222584 in newly diagnosed GBM
22952
No Radiotherapy versus Whole Brain Radiotherapy for 1 to 3 Brain Metastases from Solid Tumor after Surgical Resection or Radiosurgery. A Randomized Phase III Trial.
26052
Phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed Glioblastoma
26081
Phase III Intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with Newly Diagnosed Anaplastic Oligodendroglioma or Anaplastic Mixed Glioma with Chromosomal Co-delections of 1p and 19q.
26091
Randomized trial assessing the significance of Bevacizumab in recurrent grade II and Grade III gliomas. The TAVAREC trial.
26082
Radiation therapy and concurrent plus adjuvant Temsirolimus (CCI-779) versus chemo-irradiation with temozolomide in newly diagnosed glioblastoma without methylation of the MGMT gene promoter - a randomized multicenter, open-label, Phase II study.
26083
Randomized phase II of Lomustine versus lomustine-dasatinib in patients with recurrent Glioblastoma
26062
A randomized phase III study of Temozolomide and short-course radiation versus short-course radiation alone in the treatment of newly diagnosed glioblastoma multiforme in elderly patients
26071
Cilengitide in subjects with newly diagnosed glioblastoma and methylated MGMT promoter gene- a multicenter, open-label, controlled Phase III study, testing cilengitide in combination with standard treatment (temozolomide with concomitant radiation therapy, followed by temozolomide maintenance therapy) versus standard treatment alone (CENTRIC)
22042
Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma : a Phase II and observation study
22033
Primary chemotherapy with temozolomide vs.radiotherapy in patients with low grade gliomas after stratification for genetic 1p loss : a phase III study
16027
Phase I study of SCH66336(lonafarnib), a farnesyl protein transferase inhibitor in combination with temozolomide in gliomas

Back to Site-list